Altimmune Inc
ALT
Get informed when a big investor buys or sells
+ FollowMarket Cap$238.29M
Close$
$0.09
96.9% downside
Current Fair Value
96.9% downsideOvervalued by 96.9% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $238.29 Million |
|---|---|
| Enterprise Value | $176.54 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1 |
| Beta | 0.23 |
| Outstanding Shares | 124,461,818 |
Return
| Return on Equity | -32.07% |
|---|---|
| Return on Assets | -27.14% |
| Return on Invested Capital | -29.89% |
Valuation & Multiples
| P/E Ratio | -2.9 |
|---|---|
| PEG | -19.02 |
| Price to Sales | - |
| Price to Book Ratio | 1.46 |
| Enterprise Value to Revenue | 4903.91 |
| Enterprise Value to EBIT | -1.82 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.13 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.25
Average shareholder expectationRevenue Estimate
$1,429
Average shareholder expectationNext Earnings Call
Expected Date
August 11, 2026
EPS Estimate
$-0.17
Average shareholder expectationRevenue Estimate
$1,750
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.6429▼ 70.24% |
|---|---|
| Total Calls | 1,256,400▼ 45.68% |
| Total Puts | 807,800▼ 74.04% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 78.74%▲ 17.40% |
|---|---|
| Total Invested | $213.51M▲ 7.80% |
| Investors Holding | 183▼ 18.00% |
ESG Score
No data
About Altimmune Inc
CEO: Vipin Garg